Andrew Blauvelt, Rundong Jiang, Linyu Shi, Lam C. Tsoi, Rachael Bogle, Jennifer Fox, Mehrnaz Gharaee-Kermani, Allison C. Billi, Robert T. Matheson, Huzefa Photowala, Johann E. Gudjonsson, Benjamin D. Ehst. "A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab." Nature Communications, 2025. doi:10.1038/s41467-025-67475-0